Patient#	Sample#	IP3:(PI-4-5-P2, active),	Ca2+:(IP3, active),	CAV1:(CAV1, protein),	CAV3:(CAV3, protein),	CRK:(CRK, protein),	CRKL:(CRKL, protein),	CSNK2A1:(CSNK2A1, protein),	PDGFRA:(PDGFRA, protein),	RAPGEF1:(RAPGEF1, protein),	SHB:(SHB, protein),	SHF:(SHF, protein),	alphav Integrin:(alphav Integrin, protein),	JUN:(CSNK2A1, active),(JUN, protein),	PDGF/PDGFRA:(PDGFA-B-C, active),(PDGFRA, active),	SRF:(CSNK2A1, active),(SRF, protein),	JAK1:(JAK1, protein),(PDGF/PDGFRA, active),	PDGF/PDGFRA/CRKL:(CRKL, active),(PDGF/PDGFRA, active),	PDGF/PDGFRA/Caveolin-1:(CAV1, active),(PDGF/PDGFRA, active),	PDGF/PDGFRA/Caveolin-3:(CAV3, active),(PDGF/PDGFRA, active),	PDGF/PDGFRA/Crk:(CRK, active),(PDGF/PDGFRA, active),	PDGF/PDGFRA/SHB:(PDGF/PDGFRA, active),(SHB, active),	PDGF/PDGFRA/Shf:(PDGF/PDGFRA, active),(SHF, active),	PDGF/PDGFRA/alphav Integrin:(PDGF/PDGFRA, active),(alphav Integrin, active),	PI3K:(PDGF/PDGFRA, active),	PLCG1:(PDGF/PDGFRA, active),(PLCG1, protein),	SHC/GRB2/SOS1:(PDGF/PDGFRA, active),	macrophage chemotaxis:(Interferon-gamma receptor/IFN-gamma, active),(PDGF/PDGFRA, active),	DAG:(PI-4-5-P2, active),(PLCG1, active),	JAK-STAT cascade:(JAK1, active),	PDGF/PDGFRA/Crk/C3G:(PDGF/PDGFRA/Crk, active),(RAPGEF1, active),	actin cytoskeleton reorganization:(PDGF/PDGFRA/SHB, active),	cell proliferation:(PDGF/PDGFRA/Shf, active),	oligodendrocyte development:(PDGF/PDGFRA/alphav Integrin, active),	positive regulation of JUN kinase activity:(SHC/GRB2/SOS1, active),	PKC:(Ca2+, active),(DAG, active),(PKC, protein),	ELK1:(ELK1, protein),(PKC, active),	ELK1/SRF:(ELK1, active),(SRF, active),	Ras protein signal transduction:(ELK1, active),(SHC/GRB2/SOS1, active),	AP1	FOS:(ELK1, active),(FOS, protein),	
